(Q30980357)

15 September 2017

Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients (English)

1 reference

15 September 2017

0 references

Judith Field

0 references

Justin P Rubio

0 references

Simon J Foote

0 references

Jim Stankovich

0 references

Helmut Butzkueven

0 references

Trevor J Kilpatrick

0 references

Matthew A Brown

0 references

Cathy J Jensen

1 reference

15 September 2017

Anneke Van der Walt

1 reference

15 September 2017

Melanie Bahlo

1 reference

15 September 2017

Bruce V Taylor

1 reference

15 September 2017

Ingrid A F van der Mei

1 reference

15 September 2017

Laura J Johnson

1 reference

15 September 2017

Ella Wilkins

1 reference

15 September 2017

Patrick Danoy

1 reference

15 September 2017

Australian and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene)

1 reference

15 September 2017

language of work or name

English

0 references

publication date

2 April 2010

1 reference

15 September 2017

1 reference

15 September 2017

1 reference

15 September 2017

1 reference

15 September 2017

e10003

1 reference

Creative Commons Attribution 4.0 International

15 September 2017

start time

2 April 2010

1 reference

April 2022 Public Data File from Crossref

copyrighted

0 references

cites work

Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2848851

Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2848851

Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2848851

Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2848851

Risk alleles for multiple sclerosis identified by a genomewide study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2848851

APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2848851

Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2848851

Two genes encoding immune-regulatory molecules (LAG3 and IL7R) confer susceptibility to multiple sclerosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2848851

Analysis of IL4R haplotypes in predisposition to multiple sclerosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2848851

HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2848851

HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2848851

HLA-DR15 is associated with lower age at onset in multiple sclerosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2848851

Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS. Optic Neuritis Study Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2848851

British Isles survey of multiple sclerosis in twins: MRI.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2848851

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2848851

Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis

21 June 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0010003

Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0010003

HLA genotypes and disease severity assessed by magnetic resonance imaging findings in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0010003

HLA and prognosis in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0010003

MMP-9 microsatellite polymorphism and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0010003

A population-based study of IL4 polymorphisms in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0010003

HLA-DRB1 and disease outcome in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0010003

Polymorphism analysis suggests that the gelatinase B gene is not a susceptibility factor for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0010003

Analysis of 45 candidate genes for disease modifying activity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0010003

HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2848851

Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2848851

Polymorphisms in the interleukin-4 and IL-4 receptor genes and multiple sclerosis: a study in Spanish-Basque, Northern Irish and Belgian populations

25 November 2018

1 reference

12 December 2020

The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients

1 reference

12 December 2020

Validation of linear cerebral atrophy markers in multiple sclerosis

1 reference

12 December 2020

Association of MMP1, MMP3, MMP9, and MMP12 polymorphisms with risk and clinical course of multiple sclerosis in a Polish population

1 reference

12 December 2020

Association of two variants in IL-1beta and IL-1 receptor antagonist genes with multiple sclerosis

1 reference

12 December 2020

Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis

1 reference

12 December 2020

Analysis of interleukin-4 receptor alpha chain variants in multiple sclerosis

1 reference

12 December 2020

Genetic basis for clinical expression in multiple sclerosis

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0010003

Identifiers

DOI

1 reference

15 September 2017

0 references

1 reference

15 September 2017

PubMed publication ID

20368992

1 reference